Empagliflozin-Pretreated Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Attenuated Heart Injury.
Boyu ChiAilin ZouLipeng MaoDabei CaiTingting XiaoYu WangQingjie WangYuan JiLing SunPublished in: Oxidative medicine and cellular longevity (2023)
Our data suggest that EMPA-sEV significantly improve cardiac repair after MI by inhibiting myocardial apoptosis. miR-214-3p at least partially mediated the myocardial protection of EMPA-sEV through the AKT signaling pathway.